Watch video of a Sept. 29, 2010, Lunch and Learn Event with Dr. Jeff Balser, vice chancellor for health affairs, Vanderbilt University Medical Center. Too often, physicians must base life-and-death decisions not on how an individual will respond to therapy but instead on how large groups of patients did — on average — under similar circumstances. Today, in what is being called the Post-Genome Era, we have the opportunity to develop truly personalized medicine, an approach that bases treatment not on the odds but on scientific evidence about how a patient will respond based on his or her own DNA. Dr. Jeff Balser outlines the promise of personalized medicine and its potential in health care reform.

Be the first to comment